Somatropin biosimilar - Inbiopro Solutions

Drug Profile

Somatropin biosimilar - Inbiopro Solutions

Alternative Names: IBPB 003HH

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Inbiopro Solutions
  • Class Growth hormones; Hormonal replacements; Proteins
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Somatotropin deficiency

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Somatotropin-deficiency(In children, In adults) in India
  • 16 Jul 2013 Biomarkers information updated
  • 30 Jun 2012 Clinical trials in Somatotropin deficiency (childhood onset and adulthood onset) in India (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top